CoChat

Innate Control of Tissue-Reparative Human Regulatory T Cells

The DOI matches its Crossref record; 56 of the 61 references it cites were found in a registry or an index.

Abstract

Regulatory T cell (Treg) therapy is a potential curative approach for a variety of immune-mediated conditions, including autoimmunity and transplantation, in which there is pathological tissue damage. In mice, IL-33R (ST2)–expressing Tregs mediate tissue repair by producing the growth factor amphiregulin, but whether similar tissue-reparative Tregs exist in humans remains unclear. We show that human Tregs in blood and multiple tissue types produced amphiregulin, but this was neither a unique feature of Tregs nor selectively upregulated in tissues. Human Tregs in blood, tonsil, synovial fluid, colon, and lung tissues did not express ST2, so ST2+ Tregs were engineered via lentiviral-mediated overexpression, and their therapeutic potential for cell therapy was examined. Engineered ST2+ Tregs exhibited TCR-independent, IL-33–stimulated amphiregulin expression and a heightened ability to induce M2-like macrophages. The finding that amphiregulin-producing Tregs have a noneffector phenotype and are progressively lost upon TCR-induced proliferation and differentiation suggests that the tissue repair capacity of human Tregs may be an innate function that operates independently from their classical suppressive function.

Overview

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1801330

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Research works printed but not linked: 3

  1. University of Leicester; Leicester Respiratory Biomedical Research Centre, Glenfield Hospital; Leicester Clinical Trials Unit; Genentech, Inc., 2018, Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP) (COPD-ST2OP)
  2. GlaxoSmithKline, 2017, Efficacy and safety study of GSK3772847 in subjects with moderately severe asthma
  3. GlaxoSmithKline, 2018, Repeat dose study of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD)

Cited by

See all 51

Metadata

Authors
Lam, A. J., MacDonald, K. N., Pesenacker, A. M., Juvet, S. C., Morishita, K. A., Bressler, B., iGenoMed Consortium, Pan, J. G., Sidhu, S. S., Rioux, J. D., & Levings, M. K.
Affiliations
  • University of British Columbia (CA)
  • University Health Network (CA)
  • University of Toronto (CA)
  • Montreal Heart Institute (CA)
Corresponding author
Bressler, Brian
Venue
The Journal of Immunology
Published
2019-04
Volume
202
Issue
8
Pages
2195-2209
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2922108048
Cited by
47
References
61
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 11 · 2021: 5 · 2020: 6 · 2019: 3
FWCI
2.50
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Versus Arthritis
  • Canadian Institutes of Health Research (154304_1)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
regulatory T cells, tissue repair, amphiregulin, M2 macrophages, Treg therapy, autoimmunity, transplantation, lentiviral transduction, synovial fluid, tonsil, colon, lung
MeSH terms
Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Adult, Female, Humans, Immunity, Innate, Macrophages, Male, Organ Specificity, Cell Proliferation, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.